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Abstract. 
 
Phosphorylation of the extracellular signal–
regulated kinases (ERKs) on tyrosine and threonine
residues within the TEY tripeptide motif induces ERK
activation and targeting of substrates. Although it is rec-
ognized that phosphorylation of both residues is re-
quired for ERK activation, it is not known if a single
phosphorylation of either residue regulates physiologi-
cal functions. In light of recent evidence indicating that
ERK proteins regulate substrate function in the absence
of ERK enzymatic activity, we have begun to examine
functional roles for partially phosphorylated forms of
ERK. Using phosphorylation site–speciﬁc ERK anti-
bodies and immunoﬂuorescence, we demonstrate that
ERK phosphorylated on the tyrosine residue (pY ERK)
within the TEY activation sequence is found constitu-
tively in the nucleus, and localizes to the Golgi complex
of cells that are in late G2 or early mitosis of the cell cy-
cle. As cells progress through metaphase and anaphase,
pY ERK localization to Golgi vesicles is most evident
around the mitotic spindle poles. During telophase, pY
ERK associates with newly formed Golgi vesicles but is
not found on there after cytokinesis and entry into G1.
Increased ERK phosphorylation causes punctate distri-
bution of several Golgi proteins, indicating disruption
of the Golgi structure. This observation is reversible by
overexpression of a tyrosine phosphorylation–defective
ERK mutant, but not by a kinase-inactive ERK2 mu-
tant that is tyrosine phosphorylated. These data provide
the ﬁrst evidence that pY ERK and not ERK kinase ac-
tivity regulates Golgi structure and may be involved in
mitotic Golgi fragmentation and reformation.
Key words: mitosis • Golgi complex • tyrosine phos-
phorylation • MAP kinase • cell cycle
 
Introduction
 
Extracellular signal–regulated kinase (ERK)
 
1
 
 
 
activity is
regulated by mitogen-activated protein kinase (MAPK)/
ERK kinase1/2 through phosphorylation on tyrosine (Y
 
185
 
[numbering according to mouse ERK2 sequence]; Swiss-
prot:P27703) and then threonine (T
 
183
 
), and both phos-
phorylations are required for ERK activation (Seger et al.,
1992). Although it is generally accepted that ERK activa-
tion and substrate phosphorylation are the primary means
by which ERK regulates protein function, recent data sup-
port a function for ERK proteins that is not dependent on
phosphorylation and enzymatic activity. For example, un-
phosphorylated yeast MAPK (Kss1) can repress transcrip-
tion activity through direct interactions with the Ste12
transcription factor and the nuclear proteins Dig1 and
Dig2 (Bardwell et al., 1998a,b). After activation by Ste7
MAPK kinase (MKK), the phosphorylated Kss1 can no
longer form the repressor complex and transcription can
ensue. In mammalian cells, the phosphatase activity of the
dual-specificity phosphatase MAPK phosphatase 3 (MKP-3)
can be enhanced by nonactive ERK2 interactions with
its NH
 
2
 
-terminal region (Camps et al., 1998). Additionally,
ERK2 interactions with the DNA-modifying enzyme to-
poisomerase II
 
  
 
(Topo II
 
 
 
) can enhance the ability of
Topo II
 
 
 
 to relax or decatenate DNA through a mecha-
nism that is dependent on the phosphorylation status of
ERK2, but not ERK2 activity (Shapiro et al., 1999).
Therefore, in addition to their roles as kinases, ERKs
likely possess the ability to modulate target protein func-
tion in a manner that does not require enzymatic activity.
It is not known whether partially phosphorylated forms
of ERK, including monophosphorylations on either the ty-
rosine or threonine residue within the activating site, play
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a functional role in regulating protein targets. Antibodies
have been developed against phosphotyrosine ERK (pY
ERK), phosphothreonine ERK (pT ERK), or dually phos-
phorylated ERK (pTpY ERK), and are useful tools for
studying the mechanisms of ERK activation and inactiva-
tion after growth factor stimulation (Yao et al., 2000).
These studies suggest that the phosphorylation status of
ERK is dependent on the balance between ERK kinase
and phosphatase activities, which is determined by the
subcellular location of ERK and the stimulus.
The ERK pathway is an important mediator of extracel-
lular signals that promote cell growth. ERK proteins regu-
late cell growth by promoting cell cycle transitions as cells
exit quiescence and progress through G1 into S phase.
ERK activity during G1 transitions is required for the
phosphorylation and activation of transcription factors, in-
duction of immediate early genes, enhanced cyclin D1 ex-
pression, and activation of translation factors (Beno et al.,
1995; Pelech and Charest, 1995; Lavoie et al., 1996). In
contrast, the role of the ERK pathway in regulating other
phases of the somatic cell cycle and, in particular, its role
during mitotic entry and exit, has not been clearly defined.
In the absence of stable MKK or ERK activation, activa-
tion of Raf-1 during mitosis has been reported through a
mechanism that is not dependent on Ras or typical growth
factor receptor coupling (Laird et al., 1999). However, the
targets or function of Raf-1 during mitosis are not known.
In addition, Src and Src-like proteins, which are involved
in Raf-1 and ERK pathway activation, appear to be impor-
tant mediators of G2 transition mouse fibroblasts (Roche
et al., 1995). Events downstream of Raf-1 may also func-
tion during G2/M transitions. Stable expression of nonacti-
vatable MKK1 in mouse fibroblasts has been reported to
delay G2 transition into mitosis (Wright et al., 1999). Simi-
larly, the loss of MKK2 inhibits the ability of cells to re-
cover from G2 arrest induced by ionizing radiation, sup-
porting a role for MKK2 in G2 progression (Abbott and
Holt, 1999). These examples illustrate the fact that a role
for ERK activity during G2/M has not been established,
suggesting either that MKK proteins have alternative sub-
strates, or that ERK’s involvement is through a mecha-
nism that does not require ERK activation.
In previous studies, we have reported that both MKK
and ERK proteins are activated early in mitosis, and that
ERK may modulate the phosphorylation of kinetochore
proteins that are essential for metaphase to anaphase tran-
sitions (Shapiro et al., 1998; Tolwinski et al., 1999). Cen-
tromere protein E (CENP-E), an essential kinetochore
protein, is a potential target that interacts with, and is
phosphorylated by, ERK2 (Zecevic et al., 1998). However,
the functional significance of ERK phosphorylation of
CENP-E has not been determined. Furthermore, inhibi-
tion of MKK with chemical inhibitors supported a role for
the Raf-1/MKK/ERK pathway in regulating the accumula-
tion of mitotic cells after nocodazole treatment (Hayne et
al., 2000). Recently, the ERK pathway has been impli-
cated in regulating Golgi fragmentation during mitosis.
During early mitosis, the Golgi complex disassembles,
such that Golgi components can be distributed equally to
each daughter cell and reassembled upon completion of
mitosis. The interphase Golgi network, comprised of flat-
tened stacks of cisternae, fragments into smaller stacks
and eventually forms clusters of vesicles and tubules dur-
ing mitosis (Levine et al., 1995; Shima et al., 1997). Golgi
fragmentation during mitosis is regulated by protein phos-
phorylation, and may involve activation of an ERK1/2 ac-
tivating kinase, MKK1 (Acharya et al., 1998; Colanzi et al.,
2000). Although this effect could be ascribed to MKK1 ac-
tivation, there was no evidence that ERK1/2 protein acti-
vation was involved in this process. Nonetheless, the pres-
ence of an ERK-like protein on Golgi complexes was
suggested (Acharya et al., 1998). In contrast, others report
that the cell cycle–dependent protein kinase Cdc2, and not
MKK1, is the major regulator of mitotic Golgi fragmenta-
tion (Lowe et al., 1998; Draviam et al., 2001). A proposed
mechanism for fragmentation may involve phosphoryla-
tion of Golgi structural protein GM130 at serine 25 by
Cdc2, which disrupts interactions with the vesicle-docking
protein p115 (Lowe et al., 1998). Further studies have
demonstrated that as cells transition through mitosis, the
timing of GM130 phosphorylation and dephosphorylation
correlated with the dissociation and reassociation of p115
and Golgi fragmentation (Lowe et al., 2000). In support of
both Cdc2 and MKK1, Kano et al. (2000) report that
MKK1 and Cdc2 are temporally involved in mitotic Golgi
fragmentation. These studies suggested that MKK1 is in-
volved in the initial phases of Golgi fragmentation in
which the stacks of cisternae are broken up into minis-
tacks, whereas Cdc2 is responsible for later stages of frag-
mentation in which the Golgi complex is further broken
up and vesicle fragments are more thoroughly distributed
throughout the cytoplasm.
In this work we have examined the phosphorylation sta-
tus of ERK proteins in cells, using phosphospecific ERK
antibodies in order to examine ERK regulation and func-
tion during the cell cycle. We show that pY ERK associ-
ates transiently with Golgi membranes and vesicles during
entry and exit from mitosis, and that it may regulate the
Golgi structure. These findings suggest that partially phos-
phorylated forms of ERK regulate the dynamics of subcel-
lular structures during mitosis, and that ERK proteins can
affect substrate function through mechanisms indepen-
dent of kinase activity.
 
Materials and Methods
 
Reagents and Materials
 
Stock solutions of nocodazole (5 mg/ml; Sigma-Aldrich) or taxol (4 mM;
Sigma-Aldrich) in DMSO were diluted to a final concentration of 100 ng/ml
and 1 
 
 
 
M, respectively. Lamin B (M-20), pY ERK (E-4), ERK1 (C-16),
ERK2 (C-14), and MKK1 (C-18) antibodies were purchased from Santa
Cruz Biotechnology, Inc. Other antibodies used include antiphospho-
MKK1/2 (pS217, pS221; New England Biolabs, Inc.), and anti–pY ERK
(M3682), pTpY ERK (M8159), and 
 
 
 
-tubulin (Sigma-Aldrich). Golgi anti-
bodies against p115 and GM130 (BD PharMingen/Transduction Labs) used
include Rab6 (Santa Cruz Biotechnology, Inc.), p97 Golgin (Molecular
Probes), and mannosidase II (Mann II) (gift of Dr. Marilyn Farquhar, Uni-
versity of California, San Diego, La Jolla, CA). Tyrosine-phosphorylated
and unphosphorylated ERK peptides were synthesized in the University of
Maryland Biopolymer Laboratory using the amino acid residues HTG-
FLTE(p)Y
 
185
 
VAT on ERK2, which corresponded to the sequence recog-
nized by the monoclonal pY ERK–specific antibody (Yao et al., 2000).
 
ERK2 Mutagenesis
 
Using ERK2 wild-type cDNA as a template, ERK2 tyrosine to phenylala-
nine (ERK2 TEF) mutant was generated by PCR with the following 
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primer sets: (a) forward 5
 
 
 
-GAGAAGCTTATGGCGGCGGCGGCG-3
 
 
 
(HindIII site is underlined) and reverse mutagenic 5
 
 
 
-TGTGGCCA-
CAAATTCTGTCAGGAACCC-3
 
 
 
, and (b) reverse 5
 
 
 
-TATCTCGAGT-
TAAGATCTGTATCC-3
 
 
 
 (XhoI site is underlined) and forward mu-
tagenic 5
 
 
 
-CTGACAGAATTTGTGGCCACACGT-3
 
 
 
. ERK2 TEF was
subcloned into the HindIII-XhoI site of pCDNA3 (Invitrogen), verified
by sequencing, and tyrosine-defective phosphorylation was confirmed by
the inability to be recognized by the phosphospecific ERK antibodies. An
ERK2 AEY mutant was generated by the same method.
 
Cell Culture
 
Mouse NIH 3T3, rat-kangaroo Ptk
 
1
 
, CHO, human IMR90, MCF7, or
HeLa cells were grown in DME supplemented with 10% FBS and penicil-
lin (100 U/ml)/streptomycin (100 
 
 
 
g/ml). Mouse embryonic fibroblasts
(MEFs) were provided by Drs. Gille Pages and Jacque Pouyssegur (Cen-
tre Antoine Lacassagne, Nice, France) and maintained in the above me-
dium. In some experiments, cells were transfected with cDNA (1 
 
 
 
g) for
hemagglutinin (HA)-tagged constitutively active MKK1 or 2 (Mansour et
al., 1996), and ERK2 wild-type, inactive, (AEY), or (TEF) mutant using
lipofectamine (GIBCO BRL) harvested 16–24 h after transfection.
 
Cytosol, Membrane, and Nuclear Protein Preparations
 
Nuclei were separated as described previously (Shapiro et al., 1999). In
brief, cells were harvested by scraping into a microfuge tube with extrac-
tion buffer containing 10 mM Hepes, pH 7.4, 1.5 mM MgCl
 
2
 
, 10 mM KCl,
1 mM DTT, 0.2 mM sodium orthovanadate, 1 mM benzamidine, and 0.5
mM PMSF, followed by incubation on ice for 15 min. Passing cells through
a 26-gauge needle 10 times was performed to isolate nuclei. The homoge-
nate was centrifuged at 14,000 rpm for 1 min to separate the nuclei from
the cytosolic and membrane proteins in the cytoplasmic supernatant. Nu-
clear proteins in the nuclei pellet were extracted by frequent vortexing in
20 mM Hepes, pH 7.4, 1.5 mM MgCl
 
2
 
, 25% glycerol, 420 mM NaCl, 0.2
mM EDTA, 1 mM DTT, 0.2 mM sodium orthovanadate, 1 mM benzami-
dine, and 0.5 mM PMSF. The nuclei-free cytoplasmic supernatant and the
nuclear protein fraction were further centrifuged for 1.5 h at 100,000 
 
g
 
 at
6
 
 
 
C. The supernatant fractions were saved as the cytoplasmic and nucleo-
plasmic proteins. The pellets containing the cytoplasmic and nuclear
membrane proteins were reextracted with SDS-PAGE sample buffer.
 
Protein Isolation by Sucrose Step Gradient
 
HeLa cells were transfected with ERK2 wild-type cDNA and allowed to
express protein for 16 h on six 10-cm plates. Nocodazole (100 ng/ml) was
added for an additional 6 h to three plates. Both untreated and treated
cells were rinsed in cold PBS and scraped with 1 ml of 25 mM Hepes, pH
7.4, 1 mM MgCl
 
2
 
, 1 mM DTT, 0.3 M sucrose, 0.2 mM sodium orthovana-
date, 1 mM benzamidine, and 0.5 mM PMSF. The cells were lysed with
eight strokes of a dounce homogenizer, and the supernatant was clarified
by centrifugation at 3,000 
 
g
 
 for 10 min. The supernatant was overlaid onto
1 ml each of 2 M and 1 M sucrose, and centrifuged at 100,000 
 
g
 
 for 1.5 h.
The 1/2 M sucrose interface was collected and used for immunoblotting.
 
Immunoblots
 
For examining pY ERK antibody specificity, cells were directly lysed in
SDS-PAGE sample buffer to extract soluble and membrane-bound pro-
teins. Cytosol and membrane proteins (
 
 
 
40 
 
 
 
g) and the sucrose step gra-
dient fractions prepared as described above were resolved by SDS-
PAGE. Proteins were transferred to polyvinylidene difluoride membrane,
blocked for 1–2 h with 5% nonfat dry milk in TBS (50 mM Tris, pH 7.5,
0.15 M NaCl, and 0.1% Tween 20), and incubated with primary antibodies
diluted in TBS plus 1% BSA for 2 h to overnight. Membranes were
washed several times in TBS and incubated with horseradish peroxidase–
conjugated anti–mouse or anti–rabbit antibodies (1:10,000; Jackson Im-
munoResearch Laboratories). Proteins were detected by enhanced chemi-
luminescence (NEN Life Science Products/DuPont).
For experiments examining the specificity of the phospho-ERK anti-
bodies, wild-type (His)
 
6
 
-ERK2 containing intact TEY activation site or
phosphorylation mutants ERK2 (AEY) and (TEF) were expressed in bac-
teria, purified by Ni
 
 
 
2
 
 NTA chromatography, and phosphorylated by ac-
tive MKK1 as described (Shapiro et al., 1998). The phospho-ERK immu-
noblot analysis using SDS-PAGE was performed as described above.
 
Immunofluorescence
 
Cells were grown on 18-mm-diameter coverslips (no. 1; VWR) in 6-cm tis-
sue culture plates. After treatment or transfection, coverslips were fixed in
4% paraformaldehyde for 5 min, followed by permeabilization with 0.1%
Triton X-100 for 3 min. Alternatively, cells were fixed in cold methanol for
10 min. Coverslips were incubated for 1–2 h in TBS containing 3% BSA,
followed by incubation for 1 h at room temperature with the primary anti-
bodies listed above. The coverslips were washed several times with TBS
and incubated with FITC- or Texas red–conjugated anti–mouse or anti–
rabbit secondary antibodies (Jackson ImmunoResearch Laboratories) and
counterstained with DAPI (0.2 
 
 
 
g/ml). Cells were visualized using a Nikon
E800 fluorescence microscope, recorded with a Hamamatsu digital CCD
camera, and analyzed using IP-LAB Spectrum imaging software.
Golgi structure in transfected cells was classified as described previ-
ously (Kano et al., 2000), with modifications. In brief, three phenotypes
using the Golgi markers listed above were identified according to whether
Golgi structure appeared intact, disrupted, or condensed. Intact Golgi
structure was identified by the tubular cisternae in the perinuclear region.
The disrupted Golgi structure appeared as a punctate pattern of staining
where immunoreactive spots displayed similar length and width dimen-
sions, and were significantly smaller compared with the intact tubular cis-
ternae. The condensed Golgi structure was observed in some transfected
cells with reduced cytoplasmic volume. The cells with condensed Golgi
structure were not taken into account during the quantitations, as it was
difficult to accurately assess the Golgi structure. Under each condition,
the number of transfected cells analyzed ranged from 9 to 25, 40 to 90, and
12 to 40 for HeLa, CHO, and MEF cells, respectively.
 
Results
 
Association of pY ERK with Golgi Complex
 
The development of phosphospecific antibodies that rec-
ognize mono- and diphosphorylated forms of ERK has
proved to be a useful tool for examining ERK regulation
(Yao et al., 2000). Using a phosphospecific ERK antibody
that recognizes pY ERK within the TEY activation site,
we observed a unique staining pattern in asynchronously
growing Ptk1 and 3T3 cells (Fig. 1 A). Staining for pY
ERK was evident in the nucleus of both cell lines, and in
some cells revealed a perinuclear pattern of staining (Fig. 1
A, arrows) that highly resembled the structure of the
Golgi complex. Interestingly, it appeared that in the 3T3
cells the perinuclear pY ERK staining was found in a cell
that contained condensed chromosomes resembling early
prophase of mitosis as evidenced by DAPI staining (Fig. 1
A, bottom), and suggested that the pY ERK staining pat-
tern may be cell cycle regulated.
Because the organization of the Golgi complex is regu-
lated by microtubules, and chemical-induced disruption of
microtubules causes fragmentation and dispersal of Golgi
stacks into the cytoplasm (Thyberg and Moskalewski,
1999), we compared the localization of pY ERK and the
p97 Golgin after nocodazole treatment. Microtubule dis-
ruption by nocodazole treatment caused a similar dis-
persal pattern of p97 Golgin and pY ERK staining to the
cytoplasm in both HeLa (Fig. 1 B) and MCF7 (data not
shown) cells, further supporting the localization of pY
ERK to Golgi vesicles.
To further confirm pY ERK localization to the Golgi
vesicles, cells were simultaneously stained for pY ERK
and the Golgi protein Mann II. As shown in Fig. 2, the pY
ERK only localized the perinuclear region of the cell with
condensed chromosomes indicative of mitotic prophase
(Fig. 2, second panel from top). The merged image showed
a high degree of colocalization of pY ERK and Mann II 
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(Fig. 2, bottom). In addition, the Mann II staining of the
mitotic cell in Fig. 2 appeared more diffuse compared with
the nonmitotic cell, and was indicative of early stages of
mitotic Golgi fragmentation.
Similar colocalization results were obtained by compar-
ing pY ERK and other Golgi-associated proteins, includ-
ing Rab6, GM130, and p115 (data not shown). This pat-
tern of pY ERK staining was observed in all mammalian
cells tested thus far, including NIH 3T3, HeLa, IMR90,
Ptk1, MEF, CHO, and MCF7 cells, as well as with another
pY ERK antibody (data not shown). In addition, the
pY ERK staining pattern was observed when cells were
fixed with paraformaldehyde or cold methanol (data not
shown), which further supports the biological relevance of
pY ERK found on Golgi complexes and not an introduc-
tion of a fixation artifact (Melan and Sluder, 1992). Taken
together, these data support the constitutive presence of
pY ERK in the nucleus and a cell cycle–specific associa-
tion with the Golgi complex during mitotic entry.
We have also examined the cellular localization of an
antibody raised against pT ERK and found no evidence
for localization to the Golgi complex (data not shown). In
contrast, localization of pT ERK was upregulated in
prophase cells and found at the region of the kinetochore
in mitotic cells (data not shown), and showed a similar
staining pattern as described in previous reports using the
pTpY ERK antibody (Shapiro et al., 1998).
 
Determination of pY ERK Antibody 
Specificity in Cells and In Vitro
 
We next addressed whether the pY ERK reactivity on the
Golgi complex was specific for ERK and not other cross-
reactive proteins. For these experiments, we examined the
effects of unphosphorylated and tyrosine phosphorylated
blocking peptides, which corresponded to the ERK2 pep-
tide sequence used to generate the monoclonal antibody
(Yao et al., 2000; see Materials and Methods) on pY ERK
staining. Mitotic cells in early prophase were identified af-
ter DAPI staining by the presence of condensed chromo-
somes (Fig. 3, right panels). Incubation of the pY ERK an-
tibody with the pY ERK peptide eliminated most of the
nuclear and all of the Golgi staining (Fig. 3, top left). In
contrast, untreated cells or incubation with the unphos-
phorylated ERK peptide had no effect on pY ERK stain-
ing in the nucleus or on Golgi complexes (Fig. 3, middle
and bottom left). In addition, the ERK peptides had no ef-
fect on p97, GM130, or p115 staining on Golgi complexes
(data not shown). These data provide strong evidence that
the pY ERK staining on the Golgi complex during G2/M
is specific for ERK proteins.
The specificity of the phosphospecific ERK antibodies
has been reported previously (Shapiro et al., 1998; Yao et
al., 2000). We took additional steps to confirm the pY
ERK antibody specificity using ERK2 wild-type (WT) and
phosphorylation site mutant-recombinant proteins. In Fig.
4 A (top panel), the pY ERK antibody reacted with wild-
Figure 1. Perinuclear Golgi-like staining of pY ERK2 in cells.
(A) Immunofluorescent staining for pY ERK and DAPI in Ptk1
or NIH 3T3 cells. Arrows highlight Golgi-like appearance with
pY ERK. (B) Immunofluorescent staining for p97 Golgin and pY
ERK in HeLa cells treated with nocodazole for 12 h. DAPI coun-
terstain is shown. Bars, 10  m.
Figure 2. Colocalization of
pY ERK and Mann II in
MEFs. MEFs were fixed and
costained simultaneously us-
ing antibodies against pY
ERK and Mann II. (Top)
DAPI staining of two cells
with the cell on the right side
being in prophase of mitosis.
The pY ERK and Mann II
staining are shown in the sec-
ond and third panels from
the top, respectively. (Bot-
tom) A merged image of pY
ERK (red) and Mann II
(green). Bar, 10  m. 
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type ERK2, to a significantly lesser degree with ERK2
T183A mutant in the absence of active MKK1, and not at
all with the ERK2 Y185F mutant. Although addition of
active MKK1 caused an increase in pY ERK reactivity to-
wards wild-type ERK2 and ERK2 T183A, no pY ERK re-
activity was observed with ERK2 Y185F (Fig. 4 A). It is
expected that single amino acid substitution with the
ERK2 T183A mutant would decrease the sensitivity to the
monoclonal pY ERK antibody, which was generated
against 11 amino acids encompassing the TEY activation
site (Fig. 4 A, first two lanes). Nevertheless, enhanced pY
ERK immunoreactivity in the presence of active MKK1
indicates that the antibody only recognizes pY ERK2. As
a control, the antibody against pTpY ERK2 only reacted
with wild-type ERK2 in the presence of active MKK1.
The reactivity of pY ERK and pTpY ERK was exam-
ined over time in the absence or presence of active MKK.
ERK1 in the absence of active MKK1 showed significant
pY ERK reactivity, which was slightly enhanced in the
presence of active MKK1 (Fig. 4 B, top). In contrast,
pTpY ERK reactivity was apparent after incubation for 5
min in the presence of active MKK1 and, as expected, dra-
matically increased over the course of incubation (Fig. 4 B,
middle). Total ERK1 protein is shown for comparison
(Fig. 4 B, bottom). In addition, the wild-type ERK pro-
teins in the presence of active MKK1 were the only form
of ERK with elevated kinase activity towards myelin basic
protein substrate (data not shown), supporting the re-
quirement for both threonine and tyrosine phosphoryla-
tion for ERK activation (Seger et al., 1992).
These data indicate that (a) the pY ERK antibody rec-
ognizes wild-type ERK and/or pTpY ERK, or (b) the bac-
terial ERK protein preparations are tyrosine phosphory-
lated. Several observations support the latter possibility.
First, pTpY ERK and pY ERK reactivity superimposes on
the slower- migrating phosphorylated form of ERK1 or 2,
and not the unphosphorylated ERK which migrates faster
on SDS-PAGE. This is not readily apparent in Fig. 4, but
the two forms are easily distinguishable on low-percentage
bisacrylamide gels. In addition, others have reported that
pY ERK is found in the slower-migrating form of ERK,
and thus cautioned in using ERK gel shifts as a method for
estimating ERK activation (Yao et al., 2000). In our
hands, unstimulated ERK bacterial preparations contain
some level of the slower-migrating form of ERK1 and 2
Figure 3. Inhibition of pY ERK staining in mitotic cells with pY
ERK–specific peptides. Fixed Ptk1 cells were stained using an
antibody against pY ERK that was incubated in the presence of a
pY ERK–specific peptide (top), an unphosphorylated ERK–spe-
cific peptide (middle), or without peptide (bottom). Using DAPI
to identify prophase cells (right), the pY ERK–specific peptide
effectively eliminated the nuclear and perinuclear pY ERK stain-
ing (left). Bar, 10  m.
Figure 4. Specificity of the pY ERK antibody in vitro. (A)
ERK2 wild-type (WT), and phosphorylation mutants ERK2
T183A and ERK2 Y185F were incubated in the absence or pres-
ence of active MKK1. The reaction products were resolved on
SDS-PAGE and immunoblotted for pY ERK (top), pTpY ERK
(middle), and total ERK2 (bottom). (B) Wild-type ERK1 was in-
cubated in the absence or presence of active MKK1, and the time
course of ERK phosphorylation was examined by immunoblot-
ting for pY ERK (top), pTpY ERK (middle), and total ERK1
(bottom). (C) NIH 3T3 or HeLa cells were treated in the absence
or presence of phorbol ester (PMA, 10 7 M) for 30 min. Proteins
were extracted with sample buffer, separated by SDS-PAGE, and
immunoblotted for endogenous (End.) or exogenously expressed
(Exp.) pY ERK2 (top) or total endogenous and expressed ERK2
(bottom). CHO cells were transfected with wild-type or active
(G1C) MKK1 and wild-type ERK2 cDNAs. (D) Immunoblots
for pY ERK from lysates harvested as in C from untreated cells
and 3T3 cells treated for 6 h with nocodazole (Noc., 100 ng/ml). 
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that appears to react with the pY ERK antibody (Fig. 4).
Other evidence to support the presence of pY ERK in the
bacterial ERK preparations is shown in experiments ex-
amining pTpY reactivity in the presence of active MKK1
(Fig. 4). The pY ERK reactivity increases only slightly
compared with pTpY ERK reactivity with active MKK1,
indicating that the tyrosine residue was already phosphor-
ylated. Taken together, the in vitro data indicate that the
ERK1 and 2 protein preparations contain phosphorylated
tyrosine residues, that the pY ERK antibody is not recog-
nizing unphosphorylated or pTpY ERK, and that phos-
phorylation of the tyrosine residue within the activation
site confers pY ERK antibody specificity.
The specificity of the pY ERK antibody was also tested
by immunoblotting of cell protein lysates to determine
whether cross-reactivity with other proteins could account
for the Golgi staining. As shown in Fig. 4 C (top panel),
the pY ERK antibody recognized only endogenous and
expressed ERK2 in protein lysates extracted from HeLa,
or CHO cells treated in the absence or presence of PMA.
In these cells, there was no significant pY ERK immunore-
activity with other size proteins, further supporting this an-
tibody’s specificity for recognizing only ERK proteins. Al-
though one cross-reacting protein (
 
 
 
65 kD) was observed
in protein lysates generated from 3T3 cells, it is unlikely
that this would be the Golgi protein recognized in the cell
staining because it is not observed in the other cell lines.
Increased pY ERK1 was also evident with longer autora-
diograph exposures, and the MKK inhibitor U0126 blocked
pY ERK reactivity in these cells (data not shown). As indi-
cated above, the pY ERK–reactive band superimposed on
the gel retarded the slower-migrating form of ERK2 (Fig.
4 C, bottom panel).
The pY ERK antibody was also tested in protein lysates
generated from cells treated for 6 h with nocodazole to en-
rich for cells in G2/M. Under these conditions, 
 
 
 
30% of
the cells were in mitosis as scored by chromosome conden-
sation after DAPI staining, and 
 
 
 
60% were in G2/M as
measured using flow cytometry after propidium iodide
staining as compared with 
 
 
 
10% of untreated cells in mi-
tosis or G2/M (data not shown). Nocodazole-treated cells
showed a similar pY ERK pattern of staining as untreated
cells, indicating that the pY ERK antibody was not recog-
nizing a nonspecific protein in mitotic cells (Fig. 4 D). We
conclude that the Golgi staining observed with the pY
ERK antibody is specific for pY ERK, and not due to
cross-reactivity with an unrelated Golgi proteins.
 
Biochemical Analysis of pY ERK Association with Cell 
Membranes and Copurification with Golgi Proteins
 
The subcellular distribution of phosphorylated ERK was
examined by immunoblotting after fractionation of cell
proteins. NIH 3T3 cells were serum starved for 16 h or
treated for 6 h with nocodazole, the cytoplasm and nuclei
were separated, and the soluble and membrane protein
fractions from the cytoplasm and nuclei were isolated for
each treatment. Nocodazole treatment, which significantly
enriched the number of cells in G2/M, enhanced the pY
ERK reactivity in the cytoplasmic membrane and nucleo-
plasmic protein fractions (Fig. 5 A, Cyt./M and Nuc./C). In
contrast, dually phosphorylated ERK (pTpY ERK) reac-
tivity could be found in all fractions of serum-depleted
cells, but showed lower levels in the nuclear membrane
fraction of nocodazole-treated cells (Fig. 5 A). The loss of
pTpY reactivity under these conditions may be a conse-
quence of enhanced nuclear envelope breakdown. Total
ERK2 and MKK1 reactivity was found primarily in both
the soluble cytosolic and membrane fractions of the cyto-
plasm (Fig. 5 A). To validate the quality of the cell frac-
tionations, control immunoblots were performed against
proteins whose subcellular localization has been estab-
lished. As shown in Fig. 5 B, Mann II and nuclear lamin B
were found only in the cytoplasmic and nuclear membrane
fractions, respectively. As expected, Topo II
 
 
 
 was found
enhanced in the nucleoplasm of nocodazole-treated cells
(Fig. 5 B), but could be visible in the starved cells with
longer autoradiograph exposures (data not shown and
Shapiro et al., 1999).
To show additional biochemical evidence that pY ERK
associates with Golgi complexes, HeLa cells expressing ex-
ogenous wild-type ERK2 were treated in the absence or
presence of nocodazole for 6 h to enrich the G2/M popula-
tion. The Golgi proteins were isolated by sucrose step gra-
dient and the pY ERK reactivity was examined. Noco-
dazole-treated cells showed a discernible elevation of
expressed and endogenous pY ERK compared with the
asynchronous untreated cells (Fig. 5 C, upper panel, lane 1
vs. lane 2). Control cells expressing active MKK1 and
ERK2 wild-type are shown for comparison (Fig. 5 C, up-
per panel, lane 3). Importantly, no cross-reacting bands
were visible, indicating that the pY ERK antibody was not
recognizing a nonspecific protein in asynchronous or
G2/M enriched cells (Fig. 5 C). In addition, examination of
pTpY ERK in the same samples under identical condi-
tions showed similar reactivity to the positive control com-
pared with pY ERK, but no reactivity with expressed
ERK, and a barely reactive band with endogenous ERK
(Fig. 5 C). This was not due to a lack of phosphorylated
ERK, as nocodazole-treated cell lysates showed a signifi-
cant elevation of pTpY ERK compared with untreated
controls in cell lysates harvested in SDS-PAGE sample
buffer as in Fig. 4, C and D (Fig. 5 D). As a control, 
 
 
 
-tubu-
lin and p115 expression is shown in the lower panels of
Fig. 5 C. Thus, these data support the specific enhance-
ment of pY ERK and association with Golgi complexes
during G2/M.
 
Localization of pY ERK to Golgi Complex 
Occurs during G2/M Transitions
 
We confirmed the localization of pY ERK to Golgi com-
plexes during G2/M by staining with an antibody raised
against phosphorylated histone H3 (pH3) (Hendzel et al.,
1997). Ptk1 cells were used in these studies because of
their large size, lower chromosome number, and relatively
flat morphology during mitosis. However, similar results
have been obtained with HeLa and NIH 3T3 cells (data
not shown). The merged images of cells with Golgi-like pY
ERK staining (red) were identified and the corresponding
pH3 staining (green) confirmed that the observed pY
ERK staining correlated with cells that were in G2/M
phase of the cell cycle (Fig. 6, left). Three separate exam-
ples are shown with the corresponding DAPI staining (Fig.
6, right). The top panels of Fig. 6 are suggestive of a cell in 
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late stages of G2 or early prophase where chromosomes
have yet to fully condense, the pH3 reactivity is just begin-
ning to be revealed as punctate spots, and the Golgi struc-
ture is intact. In contrast, the lower panels clearly show
cells that contain progressively condensed chromosomes
and high immunoreactivity with pH3. The pY ERK stain-
ing in these cells around the area of the Golgi complex is
less organized, more dispersed, and indicative of early
stages of mitotic Golgi fragmentation.
 
pY ERK Association with Fragmented 
Golgi Vesicles throughout Mitosis
 
Next, we examined pY ERK localization in cells at later
stages of mitosis. Fixed cells were double stained by immu-
nofluorescence for pY ERK and Mann II, and mitotic cells
were identified using DAPI staining (Fig. 7). The pY ERK
pattern of staining in prometaphase cells displayed a punc-
tate appearance similar to that of Mann II and was local-
ized to the spindle poles (Fig. 7, top). Cells in metaphase
and anaphase also showed pY ERK staining at the spindle
poles, in addition to punctate staining in the region sur-
rounding the poles during metaphase (Fig. 7, middle). This
punctate clustering pattern around the spindle poles was
also observed with the Golgi-specific p115 and GM130
proteins during metaphase (data not shown). Mann II
staining showed punctate staining in the region of the spin-
dle poles and throughout the cytoplasm during metaphase,
suggesting some dissociation of pY ERK with Golgi vesi-
cles. Some punctate pY ERK staining around the spindle
poles was found in anaphase cells, although this was not as
readily evident as during metaphase (Fig. 7, middle). Dur-
ing late telophase, pY ERK is detected on the newly form-
ing Golgi structures in each of the daughter cells (Fig. 7,
bottom). These data indicate that pY ERK remains associ-
ated with population Golgi vesicles in the region of the mi-
totic spindles after prometaphase of mitosis, and that it
may function in the reformation of Golgi complexes dur-
ing completion of cell division.
 
Overexpression of Active MKK1 Alters the Staining 
Pattern of p115 and Mann II in HeLa and CHO Cells
 
To establish a direct relationship between the ERK path-
way and the Golgi complex, we examined the effects of ac-
tive MKK1 and ERK phosphorylation on the localization
of Golgi proteins. HeLa cells were transfected with
cDNAs encoding ERK2 wild-type and MKK1 or 2 wild-
type or active MKK1 or 2 mutants. Transfected cells were
identified by ERK2 overexpression, and p115 localization
Figure 5. pY ERK associates
with cellular membranes of frac-
tionated cells enriched in G2/M.
NIH 3T3 cells were incubated in
low serum (0.5% FBS) for 16 h
(Starved) or treated with no-
codazole (100 ng/ml) for 6 h,
and the soluble cytosolic (C) or
membrane (M) proteins associ-
ated with the cytoplasm (Cyt.)
or nuclei (Nuc.) were isolated.
(A) Immunoblots for pY ERK,
pTpY ERK, total ERK2, or
MKK1, and (B) for Mann II,
lamin B, or Topo II  from frac-
tionated cell proteins. (C) pY
ERK reactivity in proteins iso-
lated by sucrose gradient. Top
two panels show immunoblots
for pY ERK or pTpY ERK in
the 1M/2M sucrose gradient in-
terface from growing (lane 1) or
HeLa cells treated with nocoda-
zole for 6 h (lane 2) to enrich for
G2/M phase cells. The location
of expressed (Exp.) and endog-
enous (End.) ERK2 protein is
indicated with arrows, and the
numbers on the left indicate the
approximate size in kD. Bottom
two panels show immunoblots
for   -tubulin and p115 in the
same fractions used in the upper
panels. Lane 3 contains cell ly-
sates from HeLa cells trans-
fected with active MKK1 and
wild-type ERK2 that were harvested by direct lysis in SDS-PAGE sample buffer. (D) Immunoblots for pTpY ERK and total ERK2
from lysates harvested as in Fig. 4, C and D, from untreated and HeLa cells treated for 6 h with nocodazole (100 ng/ml). 
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was monitored simultaneously by immunofluorescence.
Three characteristic p115 patterns of staining in the MKK
transfected cells were observed corresponding to intact
(I), disrupted (D), and condensed (C) Golgi complex (Fig.
8 A, top). Although untransfected cells showed typical in-
tact Golgi structure, the active MKK transfected cells
showed a significant number of cells with a diffuse and of-
ten punctate p115 staining pattern indicative of disrupted
Golgi structure (Fig. 8 A, top left). Furthermore, 
 
 
 
20–
25% of the active MKK transfected cells (compared with
 
 
 
10% of the wild-type transfected cells) showed a reduc-
tion in cell volume and a condensed Golgi structure (Fig. 8
A). The staining pattern of p115 and Golgi morphology in
the condensed cells could not be accurately evaluated,
thus only intact and disrupted Golgi structures were com-
pared. This was important because many of the smaller
cells containing condensed Golgi structure also showed
signs of cell death as indicated by the appearance of con-
densed chromosomes (data not shown), and we wanted to
reduce interpretation errors caused by indirect effects of
active MKK on Golgi structure.
Confirmation of the presence of active MKK in cells was
evident by the increased staining of expressed ERK in the
nucleus (Fig. 8 A, middle left panel) compared with cyto-
solic ERK in the MKK1 wild-type transfected cell (Fig. 8
A, middle right). In addition, the pattern of p115 staining
was similar in the MKK1 wild-type transfected cell com-
pared with adjacent nontransfected cells (Fig. 8 A, top
right panel). Approximately 50% of the active MKK
transfected cells showed a disrupted p115 staining pattern
compared with 
 
 
 
8% of the wild-type MKK transfected
cells (Fig. 8 C, left graph). Similar results were obtained in
NIH 3T3 cells (data not shown).
To further examine the disrupted Golgi appearance ob-
served in Fig. 8 A, and to test whether exogenous ERK ex-
pression was required, CHO cells were transfected with
wild-type or active MKK1, and the Golgi complex was
evaluated using Mann II staining. Similar to Fig. 8 A,
CHO cells transfected with active MKK show an increase
in the number of cells with disrupted Mann II staining and
Golgi structure (Fig. 8 B, top panel, transfected cells
marked by arrows) compared with untransfected cells.
Untransfected and transfected CHO cells were counted
and the percentage of cells with disrupted Mann II stain-
ing was determined (Fig. 8 C). Expression of wild-type
MKK1 enhanced the number of cells with disrupted Mann
II staining approximately
 
 
 
twofold compared with untrans-
fected cells. This is not surprising, as exogenous expression
of wild-type MKK increases ERK phosphorylation and
the Golgi complex may be sensitive to these changes. Nev-
ertheless, expression of active MKK1 further enhanced
the number of cells with disrupted Mann II staining by
twofold compared with wild-type MKK1 transfected cells,
supporting a role for MKK and ERK phosphorylation in
Golgi structure regulation.
 
Disruption of Mann II Staining Is Dependent
on Tyrosine Phosphorylation of ERK 
and Not the Kinase Activity of ERK
 
Next, we addressed whether tyrosine phosphorylation of
ERK was required for the disrupted p115 and Mann II
staining pattern observed in cells with active MKK, using
an ERK2 mutant where the tyrosine within the TEY acti-
vation site was mutated to a phenylalanine (TEF). MEF
cells were transfected with cDNAs for wild-type or active
MKK1 cDNA in combination with ERK2 wild-type (WT),
inactive ERK2 (K52R), or ERK2 (TEF) mutant. HA-
tagged MKK1 transfected cells were identified as in Fig. 8
B and the Mann II staining pattern was examined. Cells
transfected with the active MKK1 showed the disrupted
punctate Mann II staining pattern when compared with
wild-type MKK1 transfected cells (Fig. 9 A, top). The per-
centages of intact and disrupted cells were quantified from
three separate experiments and cells expressing active
MKK1 in the presence of wild-type or inactive ERK show
Figure 6. Localization of pY ERK on Golgi complex is specific
for cells entering mitosis. G2/M cells were identified by pH3 and
DAPI staining in asynchronous Ptk1 cells and the corresponding
pY ERK staining was examined. Three separate examples of
cells showing progression from late G2 (top) through early (mid-
dle) and late prophase of mitosis (bottom) are shown. The arrows
in the left panels highlight the perinuclear pY ERK staining in
the cells entering mitosis. In all cases where pH3 staining was
positive, the cells also showed perinuclear Golgi-like pY ERK
staining. Bar, 10  m. 
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significant increases in the number of disrupted cells com-
pared with wild-type MKK1 transfected cells (Fig. 9 B).
Importantly, coexpression of the ERK2 (TEF) mutant re-
versed the active MKK1-induced disruption of Mann II
staining on Golgi complex (Fig. 9 B). Fig. 9 C shows the
characteristic Mann II staining pattern of MEF cells trans-
fected with active MKK and wild-type ERK2 and the re-
versal with expression of ERK2 (TEF) mutant. Similar re-
sults were obtained with p115 staining in transfected HeLa
cells (data not shown).
We tested for the possibility that pY ERK may regulate
Golgi structure indirectly structural changes in the micro-
tubules. Cells transfected with active MKK1 in combina-
tion with wild-type ERK2, ERK2 (TEF), or ERK2 (AEY)
mutants and allowed to express for 16 h were treated dur-
ing the last 4 h with taxol to stabilize microtubules. Intact
or disrupted Golgi structure was evaluated by staining for
Mann II as described above. Consistent with Fig. 9 B, in-
creased tyrosine phosphorylation in ERK2 WT or (AEY)
expressing cells showed a significant enhancement of the
disrupted Golgi phenotype as compared with cells ex-
pressing the ERK2 (TEF) mutant. These data strongly
support a functional role for pY ERK and not ERK kinase
activity in mediating MKK-induced changes in Golgi pro-
tein staining patterns.
 
Discussion
 
The current data provide the first evidence for the associa-
tion of an ERK protein, which is partially phosphorylated
Figure 7. Localization of pY
ERK at other stages of mito-
sis. MEFs were coimmuno-
stained for pY ERK (left)
and Mann II (middle). Cells
in various stages of mitosis
were identified by DAPI
staining (right) and the phases
of mitosis are shown progres-
sively from prometaphase
(top) through telophase (bot-
tom). Bar, 10  m. 
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on the tyrosine residue within the TEY activation se-
quence, with Golgi membrane and vesicles during G2 and
M phase of the cell cycle. The pY ERK association with
Golgi complex was transient and was found primarily on
Golgi complex as cells entered and exited mitosis. This
transient association on Golgi complex implies a func-
tional role for pY ERK in regulating mitotic Golgi struc-
ture, specifically during fragmentation and reformation.
Furthermore, the presence of a single tyrosine phosphory-
lation within the TEY activation site of ERK suggests that
ERK proteins may affect biological functions through
mechanisms that are dependent on phosphorylation but
independent of kinase activity.
At least three examples report that ERK protein activa-
tion is not required for ERK’s ability to regulate the func-
tion of a transcription factor, phosphatase, or DNA modi-
fying enzyme (Bardwell et al., 1998a; Camps et al., 1998;
Shapiro et al., 1999). Similarly, several examples describe
a functional activation of the ERK activator proteins
MEK1/2 that occurs in the absence of concomitant ERK
activity (Abbott and Holt, 1999; Wright et al., 1999). Thus,
pY ERK involvement in the regulation of Golgi complex
during mitosis may represent another example in which
ERK regulates biological functions through a mechanism
that is independent of the ERK kinase activity. Although
existing evidence suggests otherwise, it is possible that in
vivo, pY ERK has some level of enzymatic activity when
associated with Golgi complex. Future studies using syn-
chronized cells expressing ERK phosphorylation mutants
may indeed reveal whether pY ERK possesses enzymatic
activity during G2/M.
Tyrosine phosphorylation appears to be a key signaling
component in the regulation of the Golgi structure. For
example, it has been proposed that detyrosinated microtu-
bules are important regulator of Golgi structure whereas
tyrosinated microtubules are involved in the structural
maintenance of the cell periphery (Thyberg and Mos-
kalewski, 1993). We have shown that enhanced ERK phos-
phorylation by active MKK expression causes a disruption
of the staining pattern of p115 and Mann II Golgi proteins
Figure 8.  Overexpression
of active MKK disrupts local-
ization of Golgi proteins in
cells.  Intact (I), disrupted
(D), or condensed (C) Golgi
structure were examined in
HeLa (A) or CHO (B) cells
transfected with wild-type
(WT) or active MKK cDNA
in the presence (A) or ab-
sence (B) of ERK2 wild-type
cDNA. (Top panels) p115
(A) or Mann II (B) in trans-
fected cells. Transfected cells
were identified by exogenous
ERK in cells expressing wild-
type or active MKK1 (A,
middle) or by exogenous
MKK1 expression (only the
condition with active MKK1
is shown in B, middle). (A
and B, bottom) DAPI stain-
ing. (C) Percentage of dis-
rupted p115 (HeLa) or Mann
II (CHO) staining in trans-
fected cells. Data are repre-
sentative of at least three
separate experiments. Bar,
10  m. 
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(Figs. 8 and 9). Importantly, the disrupted Golgi protein
staining could be significantly reversed by coexpression of
a nontyrosine phosphorylatable ERK mutant (Fig. 9), in-
dicating that pY ERK is an important component for reg-
ulating Golgi structure. Furthermore, an inactive non-
ATP hydrolyzing ERK protein, which could still be phos-
phorylated within the TEY activation site, did not inhibit
the ability of active MKK to induce disrupted staining pat-
tern of p115 or Mann II. Evidence that the disrupted stain-
ing pattern could also be observed in the presence of taxol
to stabilize microtubules (Fig. 9 D) suggests that pY ERK
actions on Golgi structure are not through an indirect re-
organization of the microtubules. However, definitive
proof of this awaits further study, as pY ERK effects on
Golgi complex may have occurred before the addition of
the taxol. Furthermore, the microtubule organization ap-
peared intact in transfected cells when examining 
 
 
 
-tubu-
lin staining (data not shown). Taken together, these data
support a role for the pY ERK, but not ERK activity, in
regulating Golgi structure, possibly by regulating protein–
protein interactions that promote Golgi complex disas-
sembly or inhibiting protein interactions that maintain in-
tact interphase Golgi structure.
Other cell cycle–regulating kinases may modulate the
structure of the Golgi complex. At least two cell cycle–
dependent kinases (Cdks) that are regulated by tyrosine
phosphorylation, and their interacting cyclins have been
found in association with the Golgi complex or involved in
mitotic fragmentation. Cdc2/cyclin B is one Cdk that may
interact with Golgi stacks in oocytes during mitosis (Leiss
et al., 1992) and regulate fragmentation during somatic
cell mitosis (Lowe et al., 1998). Another pY kinase, cdk2/
cyclin E, has been found in association with the Golgi
complex, although its functional significance during the
cell cycle has yet to be determined (Gaulin et al., 2000).
The serine/threonine polo-like kinase (PlK) is another im-
portant mitotic regulator affecting both centrosome matu-
ration and mitotic entry at cyclin B1 degradation and ana-
Figure 9. Disruption of Mann II localization requires ERK ty-
rosine phosphorylation but not ERK activity. (A) MEF cells
transfected with active (left) or wild-type (WT) MKK1 (right)
plus ERK2 wild-type cDNA were immunostained for Mann II.
The punctate Mann II staining pattern in the active MKK1 trans-
fected cell indicates a disruption in the Golgi structure. DAPI
staining for each condition is shown for reference. (B) Average
percentages of intact (white bars) or disrupted (black bars) Mann
II staining in cells transfected with wild-type (wt) or active MKK1 in the presence of wild-type ERK, inactive ERK (ERK2 K52R), or
ERK2 tyrosine mutation (ERK2 TEF). The average and SD of each average are shown from three separate experiments. (C) Merged
color image of Mann II–disrupted staining in MEF cells transfected with active MKK1 and ERK2 wild-type (WT) (left) or active MKK1
and ERK2 TEF mutant (right). This characteristic staining pattern was used to calculate the values shown in B. HA-transfected cells
(red), Mann II (green), and DAPI (blue) are shown in each panel. (D) The percentage of transfected MEF cells with disrupted Golgi
complex as scored by Mann II staining was determined after taxol treatment. Cells were transfected and allowed to express wild-type or
active MKK1 plus wild-type ERK2, TEF, or AEY mutants for 13 h followed by treatment with taxol (1  M) for an additional 5 h. Data
are representative of two separate experiments. The number of transfected cells examined for wild-type MKK1 plus wild-type ERK2,
or active MKK1 plus wild-type ERK2, (TEF), or (AEY) was 33, 42, 51, and 50, respectively. Bars, 10  m. 
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phase entry (Nigg, 1998). Both PlK and Cdc2 may regulate
Golgi structure via interactions with the 65-kD Golgi reas-
sembly stacking protein (GRASP65) (Lin et al., 2000). PlK
and Cdc2 can phosphorylate GRASP65 on distinct sites,
yet the biological significance of these phosphorylations is
not known.
Another function for pY signaling proteins and pY
ERK on the Golgi complex may be to regulate protein
transport events. Endocytic and exocytic protein traffick-
ing through the Golgi complex is inhibited as cells pro-
gress through mitosis (Warren, 1993). One possibility is
that pY ERK inhibits protein transport through steric hin-
drance of Golgi docking proteins, similar to how phos-
phorylation of GM130 inhibits association with the p115
docking protein during mitosis (Nakamura et al., 1997). In
addition, a role for tyrosine kinase and phosphatase activ-
ity in the formation of secretory vesicles released from the
trans-Golgi network has been suggested previously (Thy-
berg and Moskalewski, 1993; Austin and Shields, 1996;
Gaulin et al., 2000).
The mechanisms responsible for the generation of par-
tially phosphorylated forms of ERK at specific points of
the cell cycle are not known. The reported activation of
MKK1 proteins during mitotic Golgi fragmentation pro-
vides an explanation for the generation of phosphorylated
ERK (Colanzi et al., 2000). Conversely, it could be pro-
posed that the balance of serine/threonine and tyrosine
phosphatase activities at the Golgi complex is altered dur-
ing G2/M in a manner that favors increased pY ERK. Pro-
tein phosphatase activity is likely involved in regulating
Golgi function. A large scaffolding centrosome and Golgi-
localized PKN-associated protein (CG-NAP) has been
identified that not only interacts with catalytic subunits of
protein phosphatase 1 and 2A, but also with protein kinase
A (PKA) (Takahashi et al., 1999). Interestingly, a cytoso-
lic protein tyrosine phosphatase, PTP-SL, has been shown
to target ERK and is downregulated after phosphorylation
on a serine residue by PKA (Blanco-Aparicio et al., 1999).
A proposed mechanism for the generation of pY ERK and
localization to Golgi complex could involve Golgi-associ-
ated PKA targeting and downregulation of protein tyro-
sine phosphatase. Future experiments will need to address
cell cycle–regulated changes in Golgi phosphatase activity
and the corresponding ERK phosphorylation. The spatial
and temporal regulation of ERK kinases and phos-
phatases in response to stimuli or cell cycle progression
will likely be a determinant of the phosphorylation status
and subcellular location of ERK proteins.
In summary, our studies support a role for phosphory-
lated ERK proteins in regulating the Golgi complex
through activity-independent mechanisms. These findings
provide an explanation for observed increases in MKK1
activity, in the absence of ERK1 or 2 activities, and in-
volvement in mitotic Golgi fragmentation (Colanzi et al.,
2000). Furthermore, our data do not conflict with studies
that do not show an involvement of MKK1 in Golgi frag-
mentation (Lowe et al., 1998; Draviam et al., 2001). In
these studies, only active, dually phosphorylated ERK1/2
from the soluble protein fraction (but not the membrane-
bound ERK) was examined, and the role of MKK2 was
not addressed. In addition, these previous studies reported
that a three- to fourfold increase in MKK1 activity above
the endogenous levels was not sufficient to induce Golgi
fragmentation in an in vitro system. However, the phos-
phorylation status of the ERK proteins under these condi-
tions was not reported, and it is not clear whether higher
levels of MKK1 activity are needed to affect Golgi struc-
ture. The regulation of the Golgi structure and function
during mitotic transitions most likely involves a complex
array of signaling proteins that regulate structural protein
assembly and Golgi protein–protein interactions. Further
studies aimed at addressing the specific involvement of
ERK proteins in regulating Golgi function may provide
new insight into how phosphorylated forms of ERK regu-
late protein trafficking and protein–protein interactions
during mitosis.
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